News 4 u.

Back to the edition

Deals & regulation

NHS trust responses challenge claims about Palantir platform use and benefits

The Guardian

Freedom-of-information responses from 29 NHS trusts challenge NHS England’s claim that those hospitals are “realising benefits” from Palantir’s £330m Federated Data Platform. Several trusts said the system was not live or was not being operationally used, while NHS England said some counted infrastructure, back-office analysis or data submission as benefits. The discrepancy has renewed scrutiny of the contract, including claims about additional operations that NHS England previously acknowledged it could not prove were caused by the platform.

Editorial summary · Publisher article

What matters

  • Twenty-nine trusts listed as realising benefits said the platform or its applications were not in use, not live or lacked an implementation timeline.
  • NHS England said nearly 140 trusts had reported benefits, including tools used for back-office data analysis and submission rather than direct patient care.
  • The Office for Statistics Regulation is taking forward casework after NHS England conceded it could not establish cause and effect for its operations claim.
  • Palantir defended the programme, citing more operations, fewer discharge delays and improved cancer-notification performance among using trusts.

The dispute is partly about what counts as adoption

The FOI responses suggest that NHS England’s “live” or “benefiting” categories may include infrastructure and limited administrative functions, while some trusts interpret use as active deployment of applications in operations. That difference makes headline adoption figures difficult to compare without clearer definitions and verification.

Context & caveats

  • The reporting documents a discrepancy in descriptions of use; it does not by itself establish that Palantir’s software failed where it was actively deployed.
Why this made the edition

Freedom-of-information responses from 29 NHS trusts materially challenge NHS England’s public description of Palantir platform adoption and connect the dispute to contract oversight and causal claims.

Source material